Male
Dr. Vazquez-Cintron is a scientist-entrepreneur currently developing next-generation botulinum toxin medicines at Abbvie. His journey, which began in academia, took a turn towards entrepreneurship with the founding of a biotech startup and a notable stint at the United States Army Medical Research Institute. Armed with a PhD in Immunology and Molecular & Cell Biology, his expertise lies in aligning scientific strategies with business goals.